TriFlo Cardiovascular Inc.
PrivateLast Round
Series B
Jan 23, 2024
Total Funding Raised
$15.47M
Company Overview
TriFlo Cardiovascular Inc. operates in Healthcare & Life Sciences and is based in Newport Beach, California. Its latest recorded funding round was a Series A round in June 2022.
TriFlo Cardiovascular Inc. is a biotechnology company that develops a transcatheter system to treat tricuspid valve regurgitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TriFlo Cardiovascular Inc. Comparables
Compare TriFlo Cardiovascular Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Coramaze Technologies | 89% | |
| CroíValve | 89% | |
| StarTric | 88% |
For institutional investors. Book with your work email.
TriFlo Cardiovascular Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 23, 2024 | ||||
| Series A | Jun 16, 2022 | ||||
| VC Round | Jul 22, 2020 | ||||
| Angel | Jul 2, 2019 | ||||
| Seed | Nov 22, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
TriFlo Cardiovascular Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altano Capital | Series A |
| Ceros Capital Markets | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors increased 70% MoM.
- May 1, 2025
Monthly visitors grew 103% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
TriFlo Cardiovascular Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TriFlo Cardiovascular Inc.'s valuation, stock price, and market status.
Is TriFlo Cardiovascular Inc. a public or private company?
TriFlo Cardiovascular Inc. is a private company.
What is the current stock price of TriFlo Cardiovascular Inc.?
TriFlo Cardiovascular Inc. is a private company, so its shares have no public market price. Caplight tracks TriFlo Cardiovascular Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TriFlo Cardiovascular Inc. worth (valuation)?
Valuation information for TriFlo Cardiovascular Inc. is not publicly available.
Can I buy TriFlo Cardiovascular Inc. stock?
TriFlo Cardiovascular Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TriFlo Cardiovascular Inc.'s last funding round?
TriFlo Cardiovascular Inc.'s most recent funding round was Series B on January 23, 2024.
Who are the main investors in TriFlo Cardiovascular Inc.?
Key investors in TriFlo Cardiovascular Inc. include Altano Capital, Ceros Capital Markets.
Will TriFlo Cardiovascular Inc. IPO soon?
No public IPO plans have been announced for TriFlo Cardiovascular Inc..
How can I track TriFlo Cardiovascular Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TriFlo Cardiovascular Inc.'s shares on secondary markets.